SHO Rallies Into Earnings With Shorts Caught Leaning Wrong Way

SHO enters its November 6 earnings date having gained 12% over the past month, with short sellers sitting on a position that has barely moved even as the stock runs higher.

Short interest is the most interesting tension here. At 8.2% of the free float, shorts remain meaningfully committed, yet the position has gone almost nowhere over the week, down just 0.03%. Over the past month, however, the raw share count climbed 14%, a build that preceded much of the stock's rally. That combination, a rebuilt short base sitting in a rising stock, is what gives the setup its edge this week. Borrow costs are low at 0.48%, up about 7% on the week but nowhere near punishing levels. Availability is extremely loose at 3,627%, meaning there are more than 36 shares available to lend for every one already borrowed. The borrow market is not tight, and there is no squeeze pressure from the lending side. That said, options traders have turned slightly more bullish than usual. The put/call ratio is 0.56, about 0.8 standard deviations below its 20-day average of 0.62. Calls have been outweighing puts for several weeks, with the PCR falling sharply from readings above 1.4 back in mid-September. The options market now tilts toward the bullish end, though not at an extreme.

The Street is divided on whether the rally deserves to go further. JP Morgan's Daniel Politzer raised his target this morning from $10 to $11 while keeping an Underweight rating, a concession that the stock has moved past his prior anchor but not a change of view. The current share price of $12.40 already trades above his new target. Meanwhile, Wells Fargo maintains Overweight with a $13 target, and Evercore ISI holds Outperform also at $13. Truist is at Hold with a $13 target. The consensus mean target across the group is $12.04, which puts the stock fractionally above the average Street view. Valuation has expanded alongside the price: the price-to-book ratio has moved up about 0.11 points over the past 30 days to 1.04x, and EV/EBITDA has drifted up by about 0.28 turns to 13.6x. On factor scores, EPS momentum over 30 days ranks in the 86th percentile, a sharp positive inflection. Longer-term EPS momentum over 90 days ranks in just the 3rd percentile, and the EPS surprise score is in the 15th percentile, reflecting a track record of missing estimates. That tension between recent near-term estimate upgrades and a poor history of beating consensus is central to how the November print will be read.

The most recent earnings history reinforces the caution. SHO fell 5.1% the day after its August 2026 results and dropped 6.8% over the following five days. The prior print, from Q1, produced a 2.8% next-day decline and a 7.0% five-day loss. Two consecutive post-earnings declines averaging roughly 5% on the day set a clear recent pattern. The ORTEX short score has eased slightly over the past week, from 51.9 to 50.7, reflecting the modest short covering, but at the midpoint of its range it does not point strongly in either direction.

On the institutional side, BlackRock is the dominant holder at close to 19% of shares, and added over 2 million shares in the period ended September 30. TIAA added a substantial 3.2 million shares in the same period, a notable accumulation for a name of this size. Qube Research built a position from near zero to 3.1 million shares through June. These are the flows that support the stock's technical strength, index-weight passive buyers and active managers adding together.

Peers have broadly moved in the same direction this week. HST gained 6.8% on the week, APLE 7.7%, and INN gained 9.3%. SHO's 6.4% weekly gain puts it roughly in line with the group, suggesting the move is sector-driven rather than stock-specific. The November 6 print is therefore less about whether the hospitality recovery thesis holds and more about whether SHO can finally produce a quarter that does not hand the bears a fresh reason to rebuild.